Myriad Genetics, a Utah-based company, vowed Wednesday to "vigorously defend" itself against a legal challenge to its patents on two human genes linked to breast and ovarian cancers, its attorney told CNN.
No drug on the market can block Alzheimer's, but biotech Myriad Genetics has one in the works that may slow it down.
"I wondered if it would be inevitable" that I would get breast cancer, says a young brunette in a dramatic TV ad that has been airing in Denver and Atlanta for the past six months; soon the campaig...
Money Magazine: Market Benchmarksupdated: Fri Sep 01 2000 00:01:00
MARKET MEASURES % total return Level 3 months 1 year 3 years[1] S&P 500 1510.0 11.6 9.3 19.7 Nasdaq 4246.2 27.9 50.7 40.7 Russell 2000 542.6 20.0 19.1 11.6 Morgan Stanley EAFE2 1686.9 0.7 13.6 8.3 ...
Money Magazine: Market Benchmarksupdated: Tue Aug 01 2000 00:01:00
MARKET MEASURES % total return Level 3 months 1 year 3 years[1] S&P 500 1464.5 0.7 11.4 19.6 Nasdaq 3860.6 -18.2 53.3 39.2 Russell 2000 513.7 -10.3 18.0 10.7 Morgan Stanley EAFE[2] 1681.5 -4.1 15.3...
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|